Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs OmicronWaves

被引:8
作者
Doll, Margaret K. [1 ]
Waghmare, Alpana [2 ,3 ]
Heit, Antje [4 ]
Shakoor, Brianna Levenson [5 ]
Kimball, Louise E. [3 ]
Ozbek, Nina [3 ]
Blazevic, Rachel L. [3 ]
Mose, Larry [3 ]
Boonyaratanakornkit, Jim [3 ]
Stevens-Ayers, Terry L. [3 ]
Cornell, Kevin [6 ]
Sheppard, Benjamin D. [6 ]
Hampson, Emma [6 ]
Sharmin, Faria [1 ]
Goodwin, Benjamin [5 ]
Dan, Jennifer M. [5 ,7 ]
Archie, Tom [6 ]
O'Connor, Terry [6 ,8 ]
Heckerman, David [4 ]
Schmitz, Frank [4 ]
Boeckh, Michael [3 ,9 ]
Crotty, Shane [5 ,7 ]
机构
[1] Albany Coll Pharm & Hlth Sci, Dept Populat Hlth Sci, Albany, NY USA
[2] Univ Washington, Div Infect Dis, Dept Pediat, Seattle, WA USA
[3] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[4] Amazon, Seattle, WA USA
[5] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA
[6] St Lukes Med Ctr, Ketchum, ID USA
[7] Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, Dept Med, San Diego, CA USA
[8] Univ Washington, Dept Emergency Med, Seattle, WA USA
[9] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
STATES;
D O I
10.1001/jamanetworkopen.2023.1181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The US arrival of the Omicron variant led to a rapid increase in SARS-CoV-2 infections. While numerous studies report characteristics of Omicron infections among vaccinated individuals or persons with previous infection, comprehensive data describing infections among adults who are immunologically naive are lacking. OBJECTIVES To examine COVID-19 acute and postacute clinical outcomes among a wellcharacterized cohort of unvaccinated and previously uninfected adults who contracted SARS-CoV-2 during the Omicron (BA.1/BA.2) surge, and to compare outcomes with infections that occurred during the Delta wave. DESIGN, SETTING, AND PARTICIPANTS This prospective multisite cohort study included community-dwelling adults undergoing high-resolution symptom and virologic monitoring in 8 US states between June 2021 and September 2022. Unvaccinated adults aged 30 to less than 65 years without an immunological history of SARS-CoV-2 who were at high risk of infection were recruited. Participants were followed for up to 48 weeks, submitting regular COVID-19 symptom surveys and nasal swabs for SARS-CoV-2 polymerase chain reaction (PCR) testing. Data were analyzed from May to October 2022. EXPOSURES Omicron (BA.1/BA.2 lineages) vs Delta SARS-CoV-2 infection, defined as a positive PCR test result that occurred during a period when the variant represented at least 50% of circulating SARS-CoV-2 variants in the participant's geographic region. MAIN OUTCOMES AND MEASURE(S) The main outcomes examined were the prevalence and severity of acute (<= 28 days after onset) and postacute (>= 5 weeks after onset) symptoms. RESULTS Among 274 participants who were immunologically naive (mean [SD] age, 49 [9.7] years; 186 [68%] female; 19 [7%] Hispanic participants; 242 [88%] White participants), 166 (61%) contracted SARS-CoV-2. Of these, 137 infections (83%) occurred during the Omicron-predominant period and 29 infections (17%) occurred during the Delta-predominant period. Asymptomatic infections occurred among 7%(95% CI, 3%-12%) of Omicron-wave infections and 0% (95% CI, 0%-12%) of Delta-wave infections. Health care use among individuals with Omicron-wave infections was 79% (95% CI, 43%-92%) lower relative to individuals with Delta-wave infections (P =.001). Compared with individuals infected during the Delta wave, individuals infected during the Omicron wave also experienced a 56%(95% CI, 26%-74%, P =.004) relative reduction in the risk of postacute symptoms and a 79% (95% CI, 54%-91%, P <.001) relative reduction in the rate of postacute symptoms. CONCLUSIONS AND RELEVANCE These findings suggest that among adults who were previously immunologically naive, few Omicron-wave (BA.1/BA.2) and Delta-wave infections were asymptomatic. Compared with individuals with Delta-wave infections, individuals with Omicronwave infections were less likely to seek health care and experience postacute symptoms.
引用
收藏
页数:14
相关论文
共 26 条
[1]   Incidence of SARS-CoV-2 infection among unvaccinated US adults during the Omicron wave [J].
Alejo, Jennifer L. ;
Chiang, Teresa P. Y. ;
Mitchell, Jonathan ;
Abedon, Aura T. ;
Jefferis, Alexa A. ;
Werbel, William ;
Massie, Allan B. ;
Makary, Martin A. ;
Segev, Dorry L. .
JOURNAL OF INTERNAL MEDICINE, 2022, 292 (06) :965-968
[2]   Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis [J].
Alkodaymi, Mohamad Salim ;
Omrani, Osama Ali ;
Fawzy, Nader A. ;
Abou Shaar, Bader ;
Almamlouk, Raghed ;
Riaz, Muhammad ;
Obeidat, Mustafa ;
Obeidat, Yasin ;
Gerberi, Dana ;
Taha, Rand M. ;
Kashour, Zakaria ;
Kashour, Tarek ;
Berbari, Elie F. ;
Alkattan, Khaled ;
Tleyjeh, Imad M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (05) :657-666
[3]   Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 [J].
Antonelli, Michela ;
Pujol, Joan Capdevila ;
Spector, Tim D. ;
Ourselin, Sebastien ;
Steves, Claire J. .
LANCET, 2022, 399 (10343) :2263-2264
[4]   Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant [J].
Bhattacharyya, Roby P. ;
Hanage, William P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07)
[5]  
Bouton TC., 2022, PREPRINT, DOI DOI 10.1101/2022.04.04.22273429
[6]  
Centers for Disease Control and Prevention, COVID DAT TRACK
[7]  
Centers for Disease Control and Prevention, Long COVID or Post-COVID Conditions
[8]   Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review [J].
Chen, Chen ;
Haupert, Spencer R. ;
Zimmermann, Lauren ;
Shi, Xu ;
Fritsche, Lars G. ;
Mukherjee, Bhramar .
JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (09) :1593-1607
[9]   Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas [J].
Christensen, Paul A. ;
Olsen, Randall J. ;
Long, S. Wesley ;
Snehal, Richard ;
Davis, James J. ;
Saavedra, Matthew Ojeda ;
Reppond, Kristina ;
Shyer, Madison N. ;
Cambric, Jessica ;
Gadd, Ryan ;
Thakur, Rashi M. ;
Batajoo, Akanksha ;
Mangham, Regan ;
Pena, Sindy ;
Trinh, Trina ;
Kinskey, Jacob C. ;
Williams, Guy ;
Olson, Robert ;
Gollihar, Jimmy ;
Musser, James M. .
AMERICAN JOURNAL OF PATHOLOGY, 2022, 192 (04) :642-652
[10]  
Clarke KEN, 2022, MMWR-MORBID MORTAL W, V71, P606, DOI 10.15585/mmwr.mm7117e3